Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
2018 · Nature Medicine · 284 citations
https://doi.org/10.1038/nm.4484
F
Francis Ayuk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
367
Papers
11.4K
Citations
55
h-index
169
i10-index
Francis Ayuk is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & CAR-T cell therapy research. The author has an h-index of 55, co-authored 312 publications.
ORCID: 0000-0001-6297-1847Papers by this author
worksMAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
2018 · Blood · 202 citations
https://doi.org/10.1182/blood-2018-01-822957
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
2024 · Med · 141 citations
https://doi.org/10.1016/j.medj.2024.03.002
HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients
2018 · Journal of Hepatology · 111 citations
https://doi.org/10.1016/j.jhep.2018.02.031
Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel
2020 · Molecular Therapy — Methods & Clinical Development · 62 citations
https://doi.org/10.1016/j.omtm.2019.12.018
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
2022 · Leukemia · 42 citations
https://doi.org/10.1038/s41375-022-01701-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat